See the DrugPatentWatch profile for vesicare
The generic name for Vesicare is solifenacin succinate. [1]
What is solifenacin succinate used for?
Solifenacin succinate is a medication used to treat symptoms of overactive bladder (OAB) in adults. These symptoms can include a sudden urge to urinate, frequent urination, and incontinence. [1]
How does solifenacin succinate work?
Solifenacin succinate is an antimuscarinic agent. It works by relaxing the bladder muscle, which helps to increase the bladder's capacity and reduce the urge to urinate. [1]
When does the patent for Vesicare expire?
The patent protection for Vesicare has expired in several markets. For example, in the United States, the patent expiry allowed for the introduction of generic versions. [2] Information on specific patent expiry dates for various regions can be found on resources like DrugPatentWatch.com. [2]
Who makes generic versions of solifenacin succinate?
Following patent expiries, multiple pharmaceutical companies have manufactured and marketed generic versions of solifenacin succinate. [3]
What are the potential side effects of solifenacin succinate?
Common side effects of solifenacin succinate can include dry mouth, constipation, blurred vision, and indigestion. Less common but more serious side effects may also occur. [1]
How does solifenacin succinate compare to other OAB treatments?
Other medications used to treat overactive bladder include anticholinergics like oxybutynin and tolterodine, as well as beta-3 adrenergic agonists like mirabegron. Each medication has a different mechanism of action and a distinct side effect profile, and the choice of treatment often depends on individual patient factors and physician recommendation. [4]
What is the typical cost of generic solifenacin succinate?
The cost of generic solifenacin succinate is generally lower than the brand-name Vesicare. Pricing can vary depending on the pharmacy, insurance coverage, and the dosage form. [3]
---
Sources:
[1] Solifenacin Succinate. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a604034.html
[2] Drug Patent Watch. https://www.drugpatentwatch.com/
[3] Solifenacin Succinate. GoodRx. https://www.goodrx.com/solifenacin-succinate
[4] Treatment of Overactive Bladder. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/urologic-diseases/overactive-bladder-training/treatment